The Safety of Radioiodine Therapy for Women of Reproductive Age
Radioiodine (131I) is an essential adjuvant treatment after thyroidectomy in patients with differentiated thyroid carcinoma as well as Graves’ disease (hyperthyroidism). Generally 131I is safe, It has some side effects. Infertility is one an important issues for patients who will consider to receiv...
Main Author: | Aisyah Elliyanti |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine, Universitas Andalas
2019-06-01
|
Series: | Journal of Midwifery |
Online Access: | http://jom.fk.unand.ac.id/index.php/jom/article/view/153 |
Similar Items
-
Uptake and effect of radioiodine exposure on SKBR-3 cell lines
by: Miftah Irramah, et al.
Published: (2019-12-01) -
Dyshormonal states of the reproductive system in women after thyroidectomy and radioiodine therapy for differentiated thyroid carcinoma
by: A.M. Kvachenyuk, et al.
Published: (2017-04-01) -
The history of radioiodine therapy beginnings
by: Pavel Olegovich Rumiantsev, et al.
Published: (2016-03-01) -
Radioiodine therapy of thyrotoxicosis in children and adolescents. Indications, efficacy and safety. Literature review
by: Pavel Olegovich Rumiantsev, et al.
Published: (2016-12-01) -
Preparation for radioiodine therapy: How to increase therapeutic efficacy and accelerate unbound radioiodine excretion
by: Matović Milovan
Published: (2013-01-01)